Verisante Technology, Inc. is a Canada-based medical device company. The Company is engaged in commercializing systems for the early detection of cancer. The Company's device portfolio includes Verisante Aura, Verisante Core and Verisante MSI Camera. Verisante Aura is a Raman spectroscopy system, designed for the early detection of all forms of skin cancer, including basal cell and squamous cell carcinoma and melanoma. The system provides diagnosis information by identifying spectral changes associated with the biochemistry of skin cancer cells in less than a second; providing immediate results. The Verisante Core is a medical equipment for the early detection of cancers including lung, colon and cervical, using an endoscopic attachment. Verisante MSI Camera is a rapid MSI imaging system, which captures images of 18 different narrow band wavelengths of light in one third of a second to capture multispectral images, which assist in oral and skin cancer detection applications.